Home - Oncology Central

12 SEP 2021Plain Language Summary / Future Oncology
A plain language summary of the ASCENT study: Sacituzumab Govitecan for metastatic...
22 SEP 2021Research Article / Future Oncology
Guideline conformity to the Stupp regimen in patients with newly diagnosed glioblastoma...
11 AUG 2021Perspective / Future Oncology
Ixazomib-lenalidomide-dexamethasone in routine clinical practice
19 AUG 2021Plain Language Summary / Future Oncology
Plain language summary of the final results from the DESTINY-Breast01 study
1 SEP 2021Plain Language Summary / Future Oncology
Plain language summary of the GARNET trial: clinical activity and safety of...
9 SEP 2021Research Article / Future Oncology
Real-world association of HER2/ERBB2 concordance with trastuzumab clinical benefit in advanced esophagogastric...

Featured

21 SEP 2021 WEBINAR

Coffee Chat: Mental health in the oncology clinic

25 AUG 2021 WEBINAR

Panel discussion: setting the roadmap for optimizing cancer clinical trials

6 AUG 2021 CLINICAL TRIALS / WEBINAR

The changing face of cell and gene therapy: impacts on planning and executing trials

14 JUL 2021 SPOTLIGHT

Spotlight on clinical trials

<img width="363" height="254" src="https://www.oncology-central.com/wp-content/uploads/2021/02/Capture-3.png" class="attachment-post-thumb size-post-thumb wp-post-image" alt="" srcset="https://www.oncology-central.com/wp-content/uploads/2021/02/Capture-3.png 363w, https://www.oncology-central.com/wp-content/uploads/2021/02/Capture-3-300x210.png 300w, https://www.oncology-central.com/wp-content/uploads/2021/02/Capture-3-165x115.png 165w, https://www.oncology-central.com/wp-content/uploads/2021/02/Capture-3-243x170.png 243w" sizes="(max-width: 363px) 100vw, 363px" /> 

24 FEB 2021
IN FOCUS 
In Focus: GioTag

<img width="415" height="280" src="https://www.oncology-central.com/wp-content/uploads/2021/02/Copy-of-Untitled-415x280.png" class="attachment-post-thumb size-post-thumb wp-post-image" alt="" /> 

15 FEB 2021
IN FOCUS 
In Focus: INSIGHT MM

<img width="415" height="280" src="https://www.oncology-central.com/wp-content/uploads/2020/12/eventpage_OC_Agendia_panel_3Feb-1-415x280.png" class="attachment-post-thumb size-post-thumb wp-post-image" alt="" /> 

24 DEC 2020
CHEMOTHERAPY
/ WEBINAR 
Panel discussion: real-world data in clinical trials

<img width="415" height="280" src="https://www.oncology-central.com/wp-content/uploads/2020/11/5-415x280.png" class="attachment-post-thumb size-post-thumb wp-post-image" alt="" /> 

9 NOV 2020
BIOMARKERS
/ PODCAST 
OCTalks: Comprehensive Genomic Profiling

<img width="415" height="280" src="https://www.oncology-central.com/wp-content/uploads/2020/11/in-association-with-415x280.png" class="attachment-post-thumb size-post-thumb wp-post-image" alt="" /> 

9 NOV 2020
IN FOCUS 
In Focus: Comprehensive Genomic Profiling

<img width="415" height="280" src="https://www.oncology-central.com/wp-content/uploads/2020/10/Untitled-design-10-415x280.png" class="attachment-post-thumb size-post-thumb wp-post-image" alt="FGFR2" /> 

21 OCT 2020
CLINICAL TRIALS
/ PODCAST 
OCTalks: targeting FGFR2 in advanced cholangiocarcinoma

Must Watch

21 SEP 2021 WEBINAR

Coffee Chat: Mental health in the oncology clinic

25 AUG 2021 WEBINAR

Panel discussion: setting the roadmap for optimizing cancer clinical trials

11 AUG 2021 DRUG DEVELOPMENT / VIDEO

Ixazomib-lenalidomide-dexamethasone in routine clinical practice

6 AUG 2021 CLINICAL TRIALS / WEBINAR

The changing face of cell and gene therapy: impacts on planning and executing trials

<img width="415" height="280" src="https://www.oncology-central.com/wp-content/uploads/2021/03/Untitled-design-70-415x280.png" class="attachment-post-thumb size-post-thumb wp-post-image" alt="" /> 

26 MAY 2021
LUNG
/ VIDEO 
Afatinib in NSCLC with uncommon EGFR mutations

<img width="415" height="280" src="https://www.oncology-central.com/wp-content/uploads/2021/03/Untitled-design-70-415x280.png" class="attachment-post-thumb size-post-thumb wp-post-image" alt="" /> 

25 MAY 2021
CLINICAL TRIALS
/ VIDEO 
Sequential afatinib and osimertinib in NSCLC patients

<img width="415" height="280" src="https://www.oncology-central.com/wp-content/uploads/2021/03/Untitled-design-70-415x280.png" class="attachment-post-thumb size-post-thumb wp-post-image" alt="" /> 

30 MAR 2021
CLINICAL TRIALS
/ VIDEO 
Darolutamide and survival in nonmetastatic, castration-resistant prostate cancer: a patient perspective of the ARAMIS trial

<img width="415" height="280" src="https://www.oncology-central.com/wp-content/uploads/2020/12/eventpage_OC_Agendia_panel_3Feb-1-415x280.png" class="attachment-post-thumb size-post-thumb wp-post-image" alt="" /> 

24 DEC 2020
CHEMOTHERAPY
/ WEBINAR 
Panel discussion: real-world data in clinical trials

<img width="415" height="280" src="https://www.oncology-central.com/wp-content/uploads/2020/10/Untitled-design-64-415x280.png" class="attachment-post-thumb size-post-thumb wp-post-image" alt="Managing colorectal cancer patients" /> 

2 OCT 2020
COLORECTAL
/ VIDEO 
Managing colorectal cancer patients in the COVID-19 era

<img width="415" height="280" src="https://www.oncology-central.com/wp-content/uploads/2020/06/840x470-25-415x280.png" class="attachment-post-thumb size-post-thumb wp-post-image" alt="" /> 

25 SEP 2020
DRUG APPROVALS
/ WEBINAR 
Panel discussion: past, present and future of immuno-oncology

Top 5 Future Oncology articles – September 2021

CHRYSALIS-2: positive Phase 1b results demonstrate efficacy of amivantamab, lazertinib and chemotherapy combination in NSCLC

First-line treatment of advanced/metastatic melanoma with anti-PD-1 antibodies: multicenter experience in Poland

Guideline conformity to the Stupp regimen in patients with newly diagnosed glioblastoma multiforme in China

ESMO21: Results of first randomized trial, FIRSTMAPPP, for rare neuroendocrine tumor

ESMO21: MONALEESA-2 trial demonstrates overall survival benefit

Panel discussion: setting the roadmap for optimizing cancer clinical trials

The changing face of cell and gene therapy: impacts on planning and executing trials

Panel discussion: how I treat non-metastatic castration-resistant prostate cancer (CRPC)

Journal Content

Featured

Coffee Chat: Mental health in the oncology clinic

Panel discussion: setting the roadmap for optimizing cancer clinical trials

The changing face of cell and gene therapy: impacts on planning and executing trials

Spotlight on clinical trials

In Focus: GioTag

In Focus: INSIGHT MM

Panel discussion: real-world data in clinical trials

OCTalks: Comprehensive Genomic Profiling

In Focus: Comprehensive Genomic Profiling

OCTalks: targeting FGFR2 in advanced cholangiocarcinoma

Must Watch

Coffee Chat: Mental health in the oncology clinic

Panel discussion: setting the roadmap for optimizing cancer clinical trials

Ixazomib-lenalidomide-dexamethasone in routine clinical practice

The changing face of cell and gene therapy: impacts on planning and executing trials

Afatinib in NSCLC with uncommon EGFR mutations

Sequential afatinib and osimertinib in NSCLC patients

Darolutamide and survival in nonmetastatic, castration-resistant prostate cancer: a patient perspective of the ARAMIS trial

Panel discussion: real-world data in clinical trials

Managing colorectal cancer patients in the COVID-19 era

Panel discussion: past, present and future of immuno-oncology

Office info

Journal Content

Featured

Must Watch

What's Trending?